newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of